logo

28.24

28.24 (0.03%)

As of Aug 09, 2022

Intersect Ent, Inc. [XENT]

Source: 

Company Overview

Intersect Ent, Inc is a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care. Our U.S. Food and Drug Administration (“FDA”) approved steroid releasing products are designed to provide mechanical spacing and deliver targeted therapy (mometasone furoate) to the site of disease.

CountryUnited States
Headquartersmenlo parkcalifornia
Phone Number650-641-2100
Industry
manufacturing
CEOThomas A. West
Websiteintersectent.com